StoneX (SNEX) chairman receives 1,101 restricted shares as annual pay
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
RADZIWILL JOHN reported acquisition or exercise transactions in this Form 4 filing.
StoneX Group Inc. director and chairman John Radziwill received a grant of 1,101 restricted shares of common stock as part of the company’s annual compensation for non-executive directors. These shares were awarded under the Restricted Stock Plan at no cash cost and will fully vest on the first anniversary of the grant date. Following this grant, he holds 102,849 shares directly and 955,158 shares indirectly through Basic Management Company Inc.
Positive
- None.
Negative
- None.
Insider Trade Summary
2 transactions reported
Mixed
2 txns
Insider
RADZIWILL JOHN
Role
Chairman of the Board
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Restricted Shares of Common Stock | 1,101 | $0.00 | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Restricted Shares of Common Stock — 102,849 shares (Direct);
Common Stock — 955,158 shares (Indirect, Through Basic Management Company Inc.)
Footnotes (1)
- [object Object]
FAQ
What insider transaction did StoneX (SNEX) report for John Radziwill?
StoneX reported that chairman and director John Radziwill received 1,101 restricted shares of common stock as part of his annual non-executive director compensation. The grant was made under the company’s Restricted Stock Plan and did not involve an open-market purchase or sale.
Is John Radziwill’s StoneX (SNEX) Form 4 grant a market buy or sell?
The Form 4 shows a grant of restricted stock, not a market buy or sell. The 1,101 shares were awarded as compensation under the company’s Restricted Stock Plan at a stated price of zero, so no open-market trading activity occurred in this transaction.
What plan governs John Radziwill’s restricted stock grant at StoneX (SNEX)?
The 1,101 restricted shares granted to John Radziwill were acquired through StoneX’s Restricted Stock Plan. The filing notes this grant is part of the annual compensation for non-executive directors, as described in the company’s proxy statement dated January 26, 2026, with full vesting after one year.